All In MedTech

Device Trial Radar · NCT04932486

Transcutaneous Electrical Stimulation in Obstructive Sleep Apnea

Randomised Controlled Trial of Transcutaneous Electrical Stimulation in Obstructive Sleep Apnea

Last checked: Nov 20, 2026Latest source record: Apr 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

42

Actual

Start

May 26, 2021

Primary completion

Apr 13, 2023

Study completion Apr 13, 2023

Sponsor

Lead sponsor
SunriseNot on our public-company list
Sponsor type
Industry
First posted
Jun 21, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this study is to assess the efficacy of transcutaneous electrical stimulation of the upper airway muscles in patients with obstructive sleep apnea.

Conditions

  • Obstructive Sleep Apnea

Interventions

  • Transcutaneous electrical stimulationDevice

    Transcutaneous electrical stimulation of the upper airway muscles

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Apnea-hypopnea index (AHI)Time frame: 6 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Respisom

    Namur, Belgium

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.